Log in

ASX:BDCBardoc Gold Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/13/2020)
Today's Range
Now: A$0.08
50-Day Range
MA: A$0.07
52-Week Range
Now: A$0.08
Volume1.58 million shs
Average VolumeN/A
Market Capitalization$110.26 million
P/E RatioN/A
Dividend YieldN/A
Bardoc Gold Limited engages in the identification, exploration, and development of mineral properties in Australia. It primarily explores for gold and manganese deposits. The company holds interest in the Aphrodite gold project, which consists of five contiguous mining leases located in the Eastern goldfields of Western Australia. It also owns interest in the Mulwarrie Gold Project located in Western Australia; the England Gold Project in the prolific Laverton gold district of Western Australia; and the Yoda gold prospect in the Northern Territory. The company was formerly known as Spitfire Materials Limited and changed its name to Bardoc Gold Limited in November 2018. Bardoc Gold Limited is based in North Fremantle, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars

Industry, Sector and Symbol

Industry Gold
Phone61 8 6215 0090



Sales & Book Value

Annual Sales$296,596.00
Cash FlowA$0.00 per share
Book ValueA$0.01 per share



Outstanding Shares1,395,719,936
Market Cap$110.26 million
Next Earnings DateN/A

Receive BDC News and Ratings via Email

Sign-up to receive the latest news and ratings for BDC and its competitors with MarketBeat's FREE daily newsletter.

Bardoc Gold (ASX:BDC) Frequently Asked Questions

How has Bardoc Gold's stock been impacted by COVID-19 (Coronavirus)?

Bardoc Gold's stock was trading at A$0.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BDC stock has increased by 43.6% and is now trading at A$0.08. View which stocks have been most impacted by Coronavirus.

Has Bardoc Gold been receiving favorable news coverage?

News stories about BDC stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Bardoc Gold earned a daily sentiment score of 1.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutBardoc Gold.

Who are some of Bardoc Gold's key competitors?

What other stocks do shareholders of Bardoc Gold own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bardoc Gold investors own include Impedimed (IPD), Cronos Group (CRON), Immunomedics (IMMU), Teck Resources (TECK), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Abbott Laboratories (ABT), Ability (ABIL), AbbVie (ABBV) and Axon Enterprise (AAXN).

Who are Bardoc Gold's key executives?

Bardoc Gold's management team includes the following people:
  • Mr. Russell Paul Hardwick C.P.A., BBus, ACIS CPA, MAICD, CFO & Company Sec. (Age 51)
  • Mr. Neil Gregory Biddle, Exec. Director
  • Mr. Robert Ryan, Chief Exec. Officer
  • Mr. Robert Andrew Johnston B.Sc, Exec. Director (Age 56)

What is Bardoc Gold's stock symbol?

Bardoc Gold trades on the ASX under the ticker symbol "BDC."

What is Bardoc Gold's stock price today?

One share of BDC stock can currently be purchased for approximately A$0.08.

How big of a company is Bardoc Gold?

Bardoc Gold has a market capitalization of $110.26 million and generates $296,596.00 in revenue each year.

What is Bardoc Gold's official website?

The official website for Bardoc Gold is www.bardocgold.com.

How can I contact Bardoc Gold?

The company can be reached via phone at 61 8 6215 0090.

This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.